1. Home
  2. BCYC vs OLP Comparison

BCYC vs OLP Comparison

Compare BCYC & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • OLP
  • Stock Information
  • Founded
  • BCYC 2009
  • OLP 1982
  • Country
  • BCYC United Kingdom
  • OLP United States
  • Employees
  • BCYC N/A
  • OLP N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • OLP Real Estate Investment Trusts
  • Sector
  • BCYC Health Care
  • OLP Real Estate
  • Exchange
  • BCYC Nasdaq
  • OLP Nasdaq
  • Market Cap
  • BCYC 492.1M
  • OLP 478.2M
  • IPO Year
  • BCYC 2019
  • OLP N/A
  • Fundamental
  • Price
  • BCYC $7.96
  • OLP $21.36
  • Analyst Decision
  • BCYC Buy
  • OLP
  • Analyst Count
  • BCYC 11
  • OLP 0
  • Target Price
  • BCYC $22.91
  • OLP N/A
  • AVG Volume (30 Days)
  • BCYC 303.4K
  • OLP 74.5K
  • Earning Date
  • BCYC 10-30-2025
  • OLP 11-04-2025
  • Dividend Yield
  • BCYC N/A
  • OLP 8.43%
  • EPS Growth
  • BCYC N/A
  • OLP N/A
  • EPS
  • BCYC N/A
  • OLP 1.29
  • Revenue
  • BCYC $19,281,000.00
  • OLP $94,839,000.00
  • Revenue This Year
  • BCYC N/A
  • OLP $11.08
  • Revenue Next Year
  • BCYC N/A
  • OLP $4.64
  • P/E Ratio
  • BCYC N/A
  • OLP $16.56
  • Revenue Growth
  • BCYC N/A
  • OLP 7.07
  • 52 Week Low
  • BCYC $6.10
  • OLP $21.35
  • 52 Week High
  • BCYC $28.67
  • OLP $30.45
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 58.20
  • OLP 35.08
  • Support Level
  • BCYC $7.40
  • OLP $21.75
  • Resistance Level
  • BCYC $8.69
  • OLP $22.30
  • Average True Range (ATR)
  • BCYC 0.38
  • OLP 0.39
  • MACD
  • BCYC 0.11
  • OLP -0.08
  • Stochastic Oscillator
  • BCYC 62.23
  • OLP 7.29

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

Share on Social Networks: